Lista de obras - Andrea Morandi - Dominio Público Uruguay

Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer

artículo científico publicado en 2019

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

artículo científico publicado en 2013

Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.

artículo científico publicado en 2018

Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival

artículo científico publicado en 2016

Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.

artículo científico publicado en 2011

GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors

artículo científico publicado en 2013

Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib

scientific article published on 10 March 2020

Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer

artículo científico publicado en 2022

Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis

artículo científico publicado en 2019

Lactate: A Metabolic Driver in the Tumour Landscape

artículo científico publicado en 2019

Linking metabolic reprogramming to therapy resistance in cancer

artículo científico publicado en 2017

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells

artículo científico publicado en 2014

Metabolic implication of tumor:stroma crosstalk in breast cancer

artículo científico publicado en 2014

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis

artículo científico publicado en 2016

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells

artículo científico publicado en 2016

Nutrient Exploitation within the Tumor-Stroma Metabolic Crosstalk

artículo científico publicado en 2016

Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase

artículo científico publicado en 2013

Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer

artículo científico publicado en 2018

RET in breast cancer: functional and therapeutic implications

scientific article published on 19 January 2011

Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer

scientific article published on 01 July 2019

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells

artículo científico publicado en 2007

Senescent stroma promotes prostate cancer progression: the role of miR-210.

artículo científico publicado en 2014

Signaling Pathways Regulating Redox Balance in Cancer Metabolism.

artículo científico publicado en 2018

Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy

Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation

artículo científico publicado en 2014

Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer

artículo científico publicado en 2014

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.

artículo científico publicado en 2015

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors

artículo científico publicado en 2017

Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts

artículo científico publicado en 2016

Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.

artículo científico publicado en 2010

The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines

artículo científico publicado en 2011

The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival

artículo científico publicado en 2015

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

scientific article published on 15 January 2020

Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts

artículo científico publicado en 2016

miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors

artículo científico publicado en 2016

Lista de obras de Andrea Morandi

Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.

Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival

Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.

GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors

Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib

Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer

Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis

Lactate: A Metabolic Driver in the Tumour Landscape

Linking metabolic reprogramming to therapy resistance in cancer

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells

Metabolic implication of tumor:stroma crosstalk in breast cancer

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells

Nutrient Exploitation within the Tumor-Stroma Metabolic Crosstalk

Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase

Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer

RET in breast cancer: functional and therapeutic implications

Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells

Senescent stroma promotes prostate cancer progression: the role of miR-210.

Signaling Pathways Regulating Redox Balance in Cancer Metabolism.

Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy

Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation

Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors

Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts

Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.

The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines

The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts

miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors